News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Agios Pharmaceuticals, Inc.
NEWS
JOBS
IN THE PRESS
AWARDS
NEWS
Genetown
Citi: Agios Pharmaceuticals’s Experimental Cancer Drug Could Provide Major Upside
November 10, 2014
·
1 min read
Genetown
Agios Pharmaceuticals Smart Buy Ahead Of Cancer Data: Citi
October 16, 2014
·
1 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Press Releases
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia
May 24, 2026
·
5 min read
Press Releases
Agios’ PYRUKYND® (mitapivat) Approved in the European Union for Adults with Thalassemia
May 24, 2026
·
15 min read
Press Releases
Agios to Present New Data at EHA 2026 Reinforcing the Significant Therapeutic Impact of Mitapivat Across Multiple Rare Hemolytic Anemias
May 12, 2026
·
21 min read
Press Releases
Agios Submits sNDA to FDA for U.S. Accelerated Approval of Mitapivat in Sickle Cell Disease
May 12, 2026
·
10 min read
Press Releases
Agios Reports First Quarter 2026 Financial Results and Provides Business Update
April 29, 2026
·
11 min read
Press Releases
Agios to Host First Quarter 2026 Financial Results Conference Call and Webcast on April 29 at 8:00 a.m. ET
April 6, 2026
·
2 min read
Press Releases
Agios Advances Mitapivat Toward Potential U.S. Accelerated Approval in Sickle Cell Disease Following Pre-sNDA Meeting with FDA
March 31, 2026
·
8 min read
Press Releases
Agios’ PYRUKYND® (mitapivat) Approved for Adults with Thalassemia in the United Arab Emirates
March 2, 2026
·
14 min read
Press Releases
Agios Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
February 12, 2026
·
10 min read
Press Releases
Agios to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call and Webcast on February 12 at 8:00 a.m. ET
January 27, 2026
·
1 min read
